patient holders will reap big rewards in the years to come....

patient holders will reap big rewards in the years to come. Still incredibly undervalued which will become apparent over the next 6 months. Like @stardestr0yer I would have said 50c was a good exit target. I now suspect 1ST has a lot of steam in it for many years evidence by the significant addressable market ahead of it so 50c may be too conservative. I note that Klaus in the investor presentation is at pains to point out that executing on these big deals (and he hints at others in the pipe) is key and suspect a few bumps on the way may be likely but respect that level of transparency to investors which I don't see much in other listed companies.